There are different levels of review the IRB determines the appropriate level of review for each project. Please refer to the Policies and Procedures in the links provided for further details about each level of review or contact us.
A study with no associated risk or minimal risk will undergo review by the Chairman of the IRB. Examples of studies that qualify for exempt or expedited review include anonymous data collection and surveys, or studies that require non-invasive testing only.
Code of Federal Regulations: 45 CFR 46.101 & 45 CFR 46.110
Full Board Review
A study that requires greater than minimal risk must be reviewed by the IRB at a convened meeting. Examples of studies that require full board review include clinical trials involving treatments, drugs or devices, and prospective cohort studies.
Code of Federal Regulations: 21 CFR 56 & 45 CFR 46
Investigator-initiated studies with minimal or greater than minimal risk will also undergo review by the OhioHealth Research Committee.
Manager, Office of Regulatory Compliance